TALIGLUCERASE ALFA

( DrugBank: Taliglucerase alfa / KEGG DRUG: Taliglucerase alfa )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	14

19. ライソゾーム病

臨床試験数 : 899 / 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

trials per page:

Showing 1 to 10 of 14 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03021941 (ClinicalTrials.gov)	July 31, 2019	23/9/2016	Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 ...	A MULTICENTER, OPEN LABEL, PHARMACOKINETICS, PHARMACODYNAMICS AND SAFETY STUDY OF ELELYSO(TM) (TALIG ...	Type 1 Gaucher Disease	Drug: Elelyso 60 units/kg	Pfizer	NULL	Withdrawn	N/A	12 Years	All	0	Phase 4	United States
2	EUCTR2011-003685-32-ES (EUCTR)	27/01/2012	13/10/2011	NA	A Multicenter Extension Study of Taliglucerase alfa in Adult Subjects with Gaucher Disease - NA	Gaucher disease MedDRA version: 14.0;Level: PT;Classification code 10018048;Term: Gaucher's disease; ...	Product Name: recombinant human glucerebrosidase Product Code: Taliglucerase Alfa INN or Proposed INN: ...	Protalix Biotherapeutics	NULL	Not Recruiting			Female: yes Male: yes	25	Phase 3	Serbia;Mexico;Canada;Spain;South Africa;Israel;Chile;Italy
3	EUCTR2011-003676-37-ES (EUCTR)	15/11/2011	14/09/2011	NA	A Multicenter Extension Study of Taliglucerase alfa in Pediatric Subjects with Gaucher Disease - NA	Gaucher disease MedDRA version: 14.0;Level: PT;Classification code 10018048;Term: Gaucher's disease; ...	Product Name: recombinant human glucerebrosidase Product Code: Taliglucerase Alfa INN or Proposed INN: ...	Protalix Biotherapeutics	NULL	Not Recruiting			Female: yes Male: yes	15	Phase 3	Spain;South Africa;Israel
4	NCT01411228 (ClinicalTrials.gov)	September 2011	4/8/2011	A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease	A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease	Gaucher Disease	Drug: Taliglucerase alfa	Pfizer	NULL	Completed	2 Years	18 Years	All	15	Phase 3	Israel;Paraguay;South Africa
5	NCT01422187 (ClinicalTrials.gov)	August 2011	22/8/2011	A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease	A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease	Gaucher Disease	Drug: Taliglucerase alfa	Pfizer	NULL	Completed	18 Years	N/A	All	19	Phase 3	NULL
6	NCT01132690 (ClinicalTrials.gov)	August 2010	26/5/2010	A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfain Pediatric Subjects With Gauch ...	A Multicenter, Double-blind, Randomized Safety and Efficacy Study of Two Dose Levels of Taligluceras ...	Gaucher Disease	Drug: Taliglucerase alfa	Pfizer	NULL	Completed	2 Years	17 Years	All	11	Phase 4	Israel;Paraguay;South Africa;United States
7	EUCTR2008-005825-12-GB (EUCTR)	17/12/2009	28/04/2009	A Phase 3 Multicenter, Open-label, Switchover Trial to Assess the Safety and Efficacy of Plant Cell ...	A Phase 3 Multicenter, Open-label, Switchover Trial to Assess the Safety and Efficacy of Plant Cell ...	Gaucher Disease MedDRA version: 9.1;Level: PT;Classification code 10018048;Term: Gaucher's disease	Product Name: UPLYSO Product Code: Taliglucerase alfa Other descriptive name: recombinant human glucoc ...	Protalix Biotherapeutics	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 3	Spain;Germany;Italy;United Kingdom
8	EUCTR2008-005825-12-DE (EUCTR)	10/12/2009	16/09/2009	A Phase 3 Multicenter, Open-label, Switchover Trial to Assess the Safety and Efficacy of Plant Cell ...	A Phase 3 Multicenter, Open-label, Switchover Trial to Assess the Safety and Efficacy of Plant Cell ...	Gaucher Disease MedDRA version: 9.1;Level: PT;Classification code 10018048;Term: Gaucher's disease	Product Name: UPLYSO Product Code: Taliglucerase alfa INN or Proposed INN: Taliglucerase alfa Other des ...	Protalix Biotherapeutics	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 3	Spain;Germany;Italy;United Kingdom
9	EUCTR2008-005826-35-GB (EUCTR)	24/06/2009	14/04/2009	A Multicenter, Double-Blind, Extension Trial of Two Parallel Dose Groups of Plant Cell Expressed Rec ...	A Multicenter, Double-Blind, Extension Trial of Two Parallel Dose Groups of Plant Cell Expressed Rec ...	Gaucher Disease MedDRA version: 9.1;Level: PT;Classification code 10018048;Term: Gaucher's disease	Product Name: UPLYSO Product Code: Taliglucerase alfa Other descriptive name: recombinant human glucoc ...	Protalix Biotherapeutics	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 3	Spain;Italy;United Kingdom
10	NCT00712348 (ClinicalTrials.gov)	December 2008	7/7/2008	Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase	A Phase 3 Multicenter, Open-label, Switchover Trial to Assess the Safety and Efficacy of Plant Cell ...	Gaucher Disease	Drug: Taliglucerase alfa	Pfizer	NULL	Completed	2 Years	N/A	All	31	Phase 3	United States;Australia;Canada;Israel;Spain;United Kingdom;Serbia

First Previous1 2Next Last